IL197920A0 - Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods - Google Patents

Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Info

Publication number
IL197920A0
IL197920A0 IL197920A IL19792009A IL197920A0 IL 197920 A0 IL197920 A0 IL 197920A0 IL 197920 A IL197920 A IL 197920A IL 19792009 A IL19792009 A IL 19792009A IL 197920 A0 IL197920 A0 IL 197920A0
Authority
IL
Israel
Prior art keywords
polypeptides
inflammatory
enhanced anti
cytotoxic properties
decreased cytotoxic
Prior art date
Application number
IL197920A
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/041791 external-priority patent/WO2007055916A2/en
Priority claimed from PCT/US2007/008396 external-priority patent/WO2007117505A2/en
Priority claimed from PCT/US2007/072771 external-priority patent/WO2008057634A2/en
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of IL197920A0 publication Critical patent/IL197920A0/en

Links

IL197920A 2006-10-27 2009-04-05 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods IL197920A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2006/041791 WO2007055916A2 (en) 2005-11-07 2006-10-27 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
PCT/US2007/008396 WO2007117505A2 (en) 2006-04-05 2007-04-03 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
PCT/US2007/072771 WO2008057634A2 (en) 2006-10-26 2007-07-03 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Publications (1)

Publication Number Publication Date
IL197920A0 true IL197920A0 (en) 2011-08-01

Family

ID=40792829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197920A IL197920A0 (en) 2006-10-27 2009-04-05 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods

Country Status (3)

Country Link
JP (1) JP2010512306A (en)
CA (1) CA2666308C (en)
IL (1) IL197920A0 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR085302A1 (en) * 2011-02-24 2013-09-18 Sanofi Sa METHOD OF PRODUCTION OF STIRATED ANTIBODIES
UY34317A (en) 2011-09-12 2013-02-28 Genzyme Corp T cell antireceptor antibody (alpha) / ß
KR102494631B1 (en) * 2013-03-11 2023-02-06 젠자임 코포레이션 Site-specific antibody-drug conjugation through glycoengineering
ES2940903T3 (en) 2014-03-19 2023-05-12 Genzyme Corp Site-specific glycomanipulation of targeting residues
KR102549282B1 (en) * 2019-11-18 2023-06-30 건국대학교 산학협력단 A Composition for Treating Inflammatory Diseases Comprising Sialylated Immunoglobulins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031826A1 (en) * 1997-01-16 1998-07-23 Cytel Corporation Practical in vitro sialylation of recombinant glycoproteins
EP1533380B1 (en) * 1999-04-15 2009-11-04 Crucell Holland B.V. Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
WO2002030954A1 (en) * 2000-10-06 2002-04-18 Kyowa Hakko Kogyo Co., Ltd. Method of purifying antibody

Also Published As

Publication number Publication date
CA2666308C (en) 2014-09-23
CA2666308A1 (en) 2008-05-15
JP2010512306A (en) 2010-04-22

Similar Documents

Publication Publication Date Title
ZA200808900B (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
EP2091969A4 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
ZA201004045B (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
IL237314A0 (en) Modified insulin polypeptides and their uses
IL185563A0 (en) Gip analog and hybrid polypeptides with selectable properties
ZA200810323B (en) Fkbp-l and uses thereof
EP2089480A4 (en) Antimicrobal materials and coatings
IL194751A0 (en) Drugs and uses
ZA200902161B (en) Antiobodies and immunoconjugates and uses therefor
ZA200904061B (en) Fuel composition and its use
PL2064327T3 (en) Dbait and uses thereof
ZA201002802B (en) Functionalised materials and uses thereof
HK1133552A1 (en) Carboranylporphyrins and uses thereof
GB0621513D0 (en) Novel polypeptides and uses thereof
SI2068909T1 (en) Modified fgf-21 polypeptides and their uses
GB0607798D0 (en) Novel polypeptides and use thereof
IL197920A0 (en) Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
ZA200904583B (en) Dual composition with warming and analgesic effects
EP1977996A4 (en) Phosphate-metal-containing complex and dense material comprising the same
EP2097085A4 (en) Therapeutic materials and methods
SI2032708T1 (en) Recombinant novirhabdoviruses and uses thereof
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
GB0907108D0 (en) Mutants and uses therefor
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0611806D0 (en) Materials and methods